packageBinimetinib

binimetinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Binimetinib is a MEK inhibitor anticancer drug used to treat melanoma and low-grade serous carcinoma. It is approved and authorised in the European Union, though one marketing application there was withdrawn.

Summary written by glm-5.3-flash from Wikidata Q19903515 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:binimetinib
ATC codes:L01EE03, L01XE
DrugBank:DB11967
PubChem CID:10288191
ChEBI:145371
Wikidata:Q19903515
formula:C17H15BrF2N4O3
molar mass:441.232 g/mol (PubChem CID 10288191)
logP:3.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown